Intravenous immunoglobulin fails to improve ARDS in patients undergoing ECMO therapy

Intravenous immunoglobulin fails to improve ARDS in patients undergoing ECMO therapy

Abstract Background Acute respiratory distress syndrome (ARDS) is associated with high mortality rates. ARDS patients suffer from severe hypoxemia, and extracorporeal membrane oxygenation (ECMO) therapy may be necessary to ensure oxygenation. ARDS has various etiologies, including trauma, ischemia-r...

Full description

Bibliographic Details
Main Authors: Stefanie Prohaska, Andrea Schirner, Albina Bashota, Andreas Körner, Gunnar Blumenstock, Helene A. Haeberle
Format: Article
Language:English
Published: BMC 2018-02-01
Series:Journal of Intensive Care
Subjects:
Intravenous immunoglobulin
ARDS
Inflammation
ECMO
Online Access:http://link.springer.com/article/10.1186/s40560-018-0278-8

Internet

http://link.springer.com/article/10.1186/s40560-018-0278-8

Similar Items